Scribd Logo
Upload

Welcome to Scribd!

  • 130 views

    GeNose C19 PDF

    Uploaded by

    Selamet Yogaswara
    The GeNose tool developed by UGM researchers can detect Covid-19 in under 2 minutes through a breath test. It analyzes volatile organic compounds in a person's breath to determine if they have Covid-19. GeNose is faster, more affordable, and accurate than PCR tests. It has a 97% accuracy rate based on clinical trials. The government hopes to distribute GeNose widely to expand testing for Covid-19 in Indonesia.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    GeNose C19 PDF

    Uploaded by

    Selamet Yogaswara
    130 views3 pages
    The GeNose tool developed by UGM researchers can detect Covid-19 in under 2 minutes through a breath test. It analyzes volatile organic compounds in a person's breath to determine if they have Covid-19. GeNose is faster, more affordable, and accurate than PCR tests. It has a 97% accuracy rate based on clinical trials. The government hopes to distribute GeNose widely to expand testing for Covid-19 in Indonesia.

    Original Title

    GeNose-C19.pdf

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The GeNose tool developed by UGM researchers can detect Covid-19 in under 2 minutes through a breath test. It analyzes volatile organic compounds in a person's breath to determine if they have Covid-19. GeNose is faster, more affordable, and accurate than PCR tests. It has a 97% accuracy rate based on clinical trials. The government hopes to distribute GeNose widely to expand testing for Covid-19 in Indonesia.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    130 views3 pages

    GeNose C19 PDF

    Uploaded by

    Selamet Yogaswara
    The GeNose tool developed by UGM researchers can detect Covid-19 in under 2 minutes through a breath test. It analyzes volatile organic compounds in a person's breath to determine if they have Covid-19. GeNose is faster, more affordable, and accurate than PCR tests. It has a 97% accuracy rate based on clinical trials. The government hopes to distribute GeNose widely to expand testing for Covid-19 in Indonesia.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 3

    UGM Innovation: GeNose Can Detect Covid-19 Less Than 2

    Minutes
    Friday, 25 September 2020 WIB, By: Natasa Adelayanti

    After launching GeNose, Universitas Gadjah Mada (UGM) formally handed over technology for the
    detection of Covid-19 from someone's breath, namely GeNose, to the Ministry of Research and
    Technology / National Agency for Research and Technology on Thursday (25/6/2020).

    This UGM researcher's innovation tool for Covid-19 detection can detect the new coronavirus in the
    human body in a fast time. People can see the test result in no less than 2 minutes of test results,
    whether they are suspected for positive or negative Covid-19.

    "Beforehand, it took about 3 minutes. However, yesterday when we examined the tool at BIN, it
    could be 80 seconds faster," said Kuwat Triyono as a member of the GeNose research team at the
    GeNose Public Expose: Covid-19 Sniffing Technology at the BJ Habibie Building. 24th floor, Jakarta.

    Apart from being expeditious to detect and have high accuracy, this tool's use is much more
    affordable than the PCR swab test. One GeNose unit, which is estimated to cost Rp. 40 million, can
    be used for 100 thousand inspections.
    "Currently, the optimum production capacity is around 50 thousand units per month," he said.

    Dian Kesumapramudya Nurputra, as another GeNose researcher, explained that GeNose works to
    detect Volatile Organic Compound (VOC) formed due to a Covid-19 infection. It comes out with the
    breath through exhalation into a specific bag. Besides, there is a sensor to identify the data and will
    be continued to be processed with artificial intelligence.

    GeNose has gone through a profiling test using 600 samples of valid data at the Bhayangkara
    Hospital and the Covid Bambanglipuro Special Field Hospital in Yogyakarta. The results show a high
    level of accuracy, namely, 97 percent. After going through the first phase of clinical trials, GeNose is
    currently entering the second stage.

    The Minister of Research and Technology/National Agency for Research and Technology, Bambang
    Brodjonegoro, highly appreciated the Covid-19 detection tool developed by the UGM research team.
    He revealed that he was eager to support GeNose's ongoing clinical trials.

    "Research/National Agency for Research and Innovation through the Covid-19 Research and
    Innovation Consortium is unhesitant to provide support for GeNose finalization efforts in the form of
    supporting phase 2 clinical trials," he said.

    He hopes that the community can immediately use GeNose massively in the middle of the pandemic.
    By the end of the year in December 2020, he is targeting the community, especially health workers,
    to use this tool.

    "If you have clinical trials and get a distribution permit from the Ministry of Health, make sure that
    the tools distributed to the Task Force are able to be used as test kits to help Indonesia to expand
    the testing ratio," he said.

    There were several attendants at the GeNose handover official ceremony. They are UGM Deputy
    Chancellor for Cooperation and Alumni, Paripurna Sugarda, and the entourage, Deputy for
    Intelligence Technology BIN, Maj. Gen. Afini Boer, Head of the Republic of Indonesia Police Medical
    and Health Center, Brigadier General Pol Rusdianto, Chair of the Research Consortium and the
    Covid-19 Innovation Ministry of Research and Technology / National Agency for Research and
    Innovation, Ali Ghufron Mukti, Plt. Deputy for Strengthening Research and Development of the
    Ministry of Research and Technology / National Agency for Research and Innovation, Muhammad
    Dimyati, a representative from the supporting industry for GeNose.
    Author: Ika
    Translator: Natasa A

    Related News

    ● GeNose Innovation Steps Up to the Diagnostic Test Phase


    ● GeNose Inventor Kuwat Triyana Receives the 2020 UGM Award
    ● UGM Innovation: GeNose, Covid-19 Detection through Breathing
    ● Sri Sultan Carries Out the Trials of UGM Covid-19 Diagnosis Tool
    ● The Chairman of Covid-19 Research and Innovation Consortium: UGM GeNose Can Be an
    Alternative for PCR Test

    You might also like